Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 4 months ago
Locationonline
ProgrammesNCP Flanders organises this webinar on the Safe and Sustainable by Design Framework: a guidance to scientists developing new chemicals or materials with the aim to make these safer and more sustainable.
It aims to
The Commission Recommendation from 8 December 2022 which announced the Framework reaches beyond HE projects, encouraging also national programmes to take up or industry to apply the framework when developing new chemicals or materials.
A representative of DG Research & Innovation from the European Commission will speak about the purpose of the framework, how it is to be used as part of a projects technical activities and the current status of the testing phase.
In a second part an expert from the Flemish Institute for Technological Research (VITO) will shed some light on the content of the SSbD framework.
There will be time for Q&A at the end of the presentations.
For registration (mandatory) click here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Defence
Security Digital, Industry & Space Cybersecurity
Digital, Industry & Space AI, data & cloud
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.